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1. Introduction 
The role of metals in metalloproteins is the object 
of much research. Metal-directed affinity labels can 
provide a new way of studying such metals and their 
near surround~gs, as well as the specific inactivation 
of met~oenzymes. The general claims for such a 
reagent are the ability to ligand a metal atom, and the 
capacity to modify an amino acid residue. A selective 
modification of amino acid residues in the metal- 
binding region of the protein may thus be attained. 
Each subunit of alcohol dehydrogenase from liver 
contains one structural and one catalytic zinc atom 
[ 11. The former has four protein ligands while the 
latter has three to the protein and one free. For the 
yeast enzyme, ihe exact number of zinc atoms is the 
subject of discussion [2,3]. 
The monodentate chelate-binding molecule, 
imidazole, binds as a free ligand to zinc in the active 
site of the liver enzyme, and can promote activation 
or inhibition of the enzyme [4,5]. Imidazole inhibits 
the yeast enzyme competitively with ethanol 
(unpublished results). It has been shown that (&Q-2- 
bromo-3(5-imidazolyl) propionic acid (BIP), prior to 
selective and irreversible alkylation of cysteine-46, 
binds reversibly at the active site zinc atom of liver 
alcohol dehydrogenase through the imidazole ring 
[6,71. 
The aim of this work has been to survey how a 
series of metal-d~ected affmity labels react with two 
metalloenzymes. Twelve imidazole derivatives are 
surveyed for inhibition and inactivation of two zinc 
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enzymes, the alcohol dehydrogenases from liver and 
yeast. Position 5 of the imidazole ring has a side 
chain, containing achlorine or bromine atom, which 
promotes alkylation of cysteine residues. Some side 
chains also contain a carboxylic acid (carboxylate 
anion), methylester or alcohol group. In three of the 
compounds the ring is 1 -methylated. Two of the 
labels have also been available as enantiomers, and 
the following paper deals with the stereospecific role 
of configuration [8]. 
Five of the derivatives were found to inactivate 
the liver enzyme and ten to inhibit; with yeast enzyme 
three inactivated and eight inhibited. 
2. Materials and methods 
The alcohol dehydrogenases were obtained from 
Boehringer bagel GmbH. The horse liver enzyme 
(cryst&ine suspension), was assayed as in f9]. The 
yeast enzyme (lyophilized) was dissolved (10 mg/ml) 
in phosphate buffer (pH 7 .O), I = 0.1 M, dialyzed 
against 4 changes of the same buffer and when 
assayed as in [6], the specific activity was 270 U/mg. 
(-)-Q-2-chloro-3(5 -imidazolyl) propionic acid 
(CIP), (--)-(,!?)-methyl2_chloro-3-(5-imidazolyl) 
propionate (CIPME), and (-)-(S)-2-chloro-3- 
(5-imidazolyl) propanol (CIPOH) were synthesized 
according to IlO], (-~~2~~oro-3~1 -methyl-S- 
~id~olyl) propionic acid (C~), (-j(,S)-methyl 
2~~oro-3~l-me~yl-5-i~d~olyl~ propionate 
(CMIPME) and (-)-(S)-2chloro-3-(1-methyld- 
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imidazolyf) propanol (AMMO according to [ 11 J , 
(~~~)-2~~oro-3~5-~id~olyl) propionic acid (CIP) 
and (+~R)-~~~yl2~~oro-3~5-~d~olyl) 
propionate (CIPME) were synthesized according to 
[IO], but starting from D-histidine instead of L-histi- 
dine. (R,S)-methyl2-bromo-3(5-imidazolyl) 
propionate (BIPME) was synthesized according to 
[ 121, S-(2-bromoethyl)-imidazole (BEI) according to 
[ 131 and S-chloromethyl-imidazole (CMI) according 
to [ 141. (R,S)-2-bromoS-(S-imidazolyl) propionic 
acid (BIP) was purchased from Sigma Chemical Co. 
2.1. Inactivations 
cuvettes at 23.S’C. For the yeast enzyme these con- 
tained 1 mM NAD*, 10 mM ethanol, 10 mM pyro- 
phosphate-Hi buffer @H 9.0) and from 1-S mM 
~bitor.~En~me was 0.08 fig@. Inhibitions of the 
liver enzyme were performed in phosphate buffer 
(PH 7.8)1= 0.1 M, with 2.4 mM NAD+, 0.5 mM 
ethanol and from 8.33-20 mM inhibitor. Enzyme 
was S E.cg/ml. Ethanol concentration was such that 
for both enzymes, it was limiting so that ethanol 
competitive inhibition emerged. Reaction was started 
by adding either enzyme to give 3.025 ml final vol. 
The initial rate of NADH production determined at 
340 nm, was used as a measure of enzyme activity. 
Yeast enzyme (0.2 mg/ml) was ~activated in phos- 
phatebuffer(pH?.O)~=O.lM~thSorlO~ 
inactivator. Aliquots (SO ~1) were withdrawn, diluted 
20 times with ice-cold phosphate buffer and assayed 
immediately. Liver enzyme (0.6 mg/ml) was inactivated 
in the same buffer with 1 or 25 mM inactivator. 
Aliquots (25 ~1) were withdrawn and assayed. All 
inactivations were performed at 23.S°C in stopped 
tubes, as also were the controls. Results were plotted 
on semi-log paper and half-times (ts) estimated from 
the inactivation curves. 
3. Resuits 
3 .l . Liver enzyme 
2 2. Inhibitions 
BlP and BIPME rapidly inactivated the liver enzyme 
(table 1). The results in [6] with BIP are confirmed. 
The corresponding chlorocompounds QCIP and 
QCIPMB also gave significant inactivation. Essentially 
no inactivation occurred with the third bromo-com- 
pound BEI. All inactivations of the liver enzyme gave 
linear semi-log captivation curves, and thus pseudo 
first-order kinetics. 
Initial rate inhibitions were carried out in quartz BE1 followed by CMI were the most potent 
Table 1 
The structure of the compounds and the inactivation results at pH 7.0 
Compound 
x-c 
Liver enzyme Yeast enzyme 
[II ‘% PI 
X Y (mM) (mW (mM) &n) 
GEIP 
(R)CIP 
(s)cIPh= 
(R)CIPME 
(SjCIPOH 
(S)CMIP 
QCMIPME 
QCMIPOH 
CM1 
BE1 
(R,S)BIP 
(R,S)BIPME 
-CHClCOOH 
-CHClCOOH 
-CHCKOOCH J 
-CHCKOOCH, 
-CHCK!H,OH 
-CHC!lCOOH 
-CHClCOOCH j 
-CHClCH,OH 
-Cl 
-CH,Br 
-CHBrCOOH 
-CHBrCOOCH, 
-H 
-H 
-H 
-H 
-H 
-CH, 
-CH, 
-CH, 
-H 
-H 
-H 
-H 
25 1350 10 
25 m 10 
25 1650 10 
2.5 OD 10 
2.5 m 10 
2.5 m 5 
25 OI) 10 
25 m 10 
2.5 OJ see text 
25 3050 10 
1 18 10 
1 40 10 
co 
26 
3750 
710 
[I] (M) is inactivator concentrations, $44 (min) the half-time of inactivation and 
‘m’ corresponds to rS > 6000 min. 
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(S)CIP 
OCiP 
(s)CIPhtE 
(R)CIPME 
FFtm 
(s)CMIP 
(Wlf= 
(f4wPQl-l 
CM 
BEI 
(RS)BiP 
(R,S)BIAME 
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Fig.1. Inhibition with the lmidazole derivatives at pH 7.8 for the liver and at pH 9.0 for the yeast enzyme. Activity with inhibitor 
is shown as a % of activity without. Column width is proportional to inhibitor concentration. This was normally 20 mM for the 
liver enzyme and 5 mM for the yeast enzyme. When different, the concentration is indicated. 
inhibitors of the liver enzyme (fig.1). (s)CIp and 
QCrPoH gave no inhibition. (S)CMIlQH inhibited, 
and the two alcohols are also substrates for the liver 
enzyme. With 10 mM alcohol, the relative activities 
for ethanol, BATH and (HUH were 1 .O, 
0.01 and 0.005, respectively. 
3 2. Yeast enzyme 
Only one chlorocompound CMI, had any significant 
inactivation effect on the yeast enzyme (table 1). 
CM1 inactivation was different from other inactiva- 
tions studied. After -3 min, the inactivation curve 
reached aplateau, which with 2.5 ,5 .O and 10 mM 
CM1 corresponded to 85%, 65% and 11% of the 
original activity, respectively. Of the bromocom- 
pounds, BE1 was found to be very reactive, BIPME 
far less reactive while BfP confirmed the results in 
[6] by giving essentially no inactivation. With BE1 
and BIPME a pseudo first-order eaction was estab- 
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lished from linear semi-log inactivation curves. 
The methyl esters BIIME and (R)CIPME were the 
most potent inhibitors of the yeast enzyme (fig.1). 
No significant ~bition was achieved with (QCB?, 
(~~~ and BIP. The other compounds gave inter- 
mediate values. 
4. Discussion 
Metal-directed affinity labelling is based on reversible 
binding to the metal. The work with BIP and the liver 
enzyme in [6 ] did not fully establish whether 
imidazole binding to zinc or the carboxylate group 
to the general anion-binding site, was the more 
important for formation of a reversible BIP-enzyme 
complex. Since BIPME and (ALE, which bear a 
neutral side chain, show the same mode of inactiva- 
tion as BIP and (S)CIp, ligand binding to zinc is 
obviously the more important. 
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Comparison of BE1 and BIPME inactivation of the 
liver enzyme shows selective dis~r~ation of an 
active site. When the me~ylester is replaced by 
hydrogen, the molecule is no longer able to inactivate 
or modify the enzyme. On the other hand, structural 
change from a carboxylate to a methyl ester group, 
which means from a negative to a neutral side chain, 
does not change the ability to inactivate. These 
results imply that the carboxylate and the methyl 
ester groups force the side chain into a position where 
alkylation can occur. 
Although the results how little correlation between 
inactivation and ~bition of the liver enzyme, all 
the captivators except (5’)CIP show some i~bition, 
That the methylesters inhibit the liver enzyme more 
than the acids is evident from the pairs (S)CIp[ 
QCIPME, (R)CIP/(R)CIPME, (S)CMIP/(S)CMIPME 
and BIP/BLPME. This indicates that a neutral side 
chain fits better into the active site of the liver 
enzyme than a negatively charged one. This also 
explains the strong inhibition with BEI. CM1 is also a 
potent inhibitor of the liver enzyme, but gave no 
inactivation. 
Due to the lack of inactivation of the yeast enzyme 
with BIP, an ability of the active-site zinc atom to 
bind a free ligand has been questioned [6]. In this 
work none of the other acids inactivated, and none 
except (R)ClP inhibited. However, BE1 and BIPME 
gave inactivation and these and several more com- 
pounds with a neutral side chain also inhibited the 
yeast enzyme. Thus, ligand binding to zinc seems to 
occur. This implies that a negatively charged side 
chain prohibits reversible binding at the active site of 
the yeast enzyme. 
Present studies confnm differences between the 
active sites of the two enzymes 161. Inhibition studies 
show that the two methylesters (R)C~E and 
BLPME are the strongest inhibitors of the yeast 
enzyme, while CM1 and BE1 most strongly inhibit the 
liver enzyme. In inactivation experiments he three 
bromo-compounds reaction differently with the two 
enzymes. BIP and BIPME give rapid inactivation of 
the liver enzyme, while the yeast enzyme was rapidly 
inactivated by BE1 and slowly by BIPME. This fits in 
with a more narrow substrate specificity of the yeast 
enzyme [ 11. 
Of the metal-directed affmity labels used in this 
work, some turned out to be reactive against the liver 
enzyme and some against the yeast enzyme. The effect 
of the labels was highly dependent upon structure. 
Me~ylation of the imidazole ring in position 1 does 
not change the chelation. capacity [ 151, but is con- 
sidered to make the ring more bulky and hydrophobic. 
Inactivation has not been found with any of the 
1 -methylated imidazole derivatives, but they turned 
out to be stronger inhibitors than those unmethylated. 
As might be expected from the better leaving roup 
properties of bromine compared with chloride, the 
bromo-compounds give much faster inactivation than 
the chloro-compounds. Labelling reagents with 
carboxylate, methylester and short aliphatic side 
chains are seen to captivate , while those with an 
alcohol side chain failed to react. 
We are aware that metal-directed affmity labels 
have potential against other zinc-proteins and proteins 
containing other metals. 
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